Susquehanna International Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $648M | Sell |
23,084,600
-5,411,700
| -19% | -$144M | 0.07% | 215 |
|
|
2025
Q4 | $710M | Buy |
28,496,300
+3,571,100
| +14% | +$90.1M | 0.08% | 191 |
|
|
2025
Q3 | $635M | Sell |
24,925,200
-675,300
| -3% | -$16.7M | 0.07% | 210 |
|
|
2025
Q2 | $621M | Sell |
25,600,500
-867,800
| -3% | -$20.2M | 0.09% | 179 |
|
|
2025
Q1 | $671M | Sell |
26,468,300
-4,468,000
| -14% | -$117M | 0.11% | 131 |
|
|
2024
Q4 | $821M | Buy |
30,936,300
+13,210,900
| +75% | +$358M | 0.12% | 119 |
|
|
2024
Q3 | $513M | Sell |
17,725,400
-4,032,400
| -19% | -$118M | 0.09% | 189 |
|
|
2024
Q2 | $609M | Buy |
21,757,800
+1,618,300
| +8% | +$44.6M | 0.11% | 140 |
|
|
2024
Q1 | $559M | Buy |
20,139,500
+7,484,300
| +59% | +$208M | 0.1% | 156 |
|
|
2023
Q4 | $364M | Buy |
12,655,200
+2,420,700
| +24% | +$73.2M | 0.07% | 230 |
|
|
2023
Q3 | $339M | Buy |
10,234,500
+3,757,600
| +58% | +$133M | 0.07% | 216 |
|
|
2023
Q2 | $238M | Buy |
6,476,900
+95,500
| +1% | +$3.72M | 0.05% | 297 |
|
|
2023
Q1 | $260M | Sell |
6,381,400
-6,100,600
| -49% | -$263M | 0.06% | 278 |
|
|
2022
Q4 | $640M | Buy |
12,482,000
+759,000
| +6% | +$36.4M | 0.16% | 90 |
|
|
2022
Q3 | $513M | Buy |
11,723,000
+302,400
| +3% | +$14.7M | 0.13% | 111 |
|
|
2022
Q2 | $599M | Buy |
11,420,600
+47,500
| +0.4% | +$2.42M | 0.15% | 92 |
|
|
2022
Q1 | $589M | Sell |
11,373,100
-12,398,900
| -52% | -$643M | 0.1% | 139 |
|
|
2021
Q4 | $1.4B | Sell |
23,772,000
-3,984,100
| -14% | -$197M | 0.21% | 62 |
|
|
2021
Q3 | $1.19B | Buy |
27,756,100
+12,507,800
| +82% | +$554M | 0.16% | 85 |
|
|
2021
Q2 | $597M | Sell |
15,248,300
-4,298,000
| -22% | -$167M | 0.08% | 193 |
|
|
2021
Q1 | $708M | Sell |
19,546,300
-8,179,100
| -30% | -$290M | 0.11% | 137 |
|
|
2020
Q4 | $1.02B | Buy |
27,725,400
+18,654,465
| +206% | +$684M | 0.17% | 79 |
|
|
2020
Q3 | $316M | Buy |
9,070,935
+4,713,804
| +108% | +$165M | 0.06% | 244 |
|
|
2020
Q2 | $135M | Sell |
4,357,131
-903,910
| -17% | -$30.7M | 0.03% | 403 |
|
|
2020
Q1 | $163M | Sell |
5,261,041
-823,069
| -14% | -$28M | 0.05% | 265 |
|
|
2019
Q4 | $226M | Sell |
6,084,110
-675,930
| -10% | -$24.1M | 0.07% | 240 |
|
|
2019
Q3 | $230M | Sell |
6,760,040
-1,380,213
| -17% | -$50.2M | 0.08% | 214 |
|
|
2019
Q2 | $335M | Buy |
8,140,253
+937,428
| +13% | +$37.2M | 0.12% | 132 |
|
|
2019
Q1 | $290M | Sell |
7,202,825
-1,453,255
| -17% | -$58.2M | 0.12% | 139 |
|
|
2018
Q4 | $358M | Sell |
8,656,080
-1,740,576
| -17% | -$72.3M | 0.14% | 112 |
|
|
2018
Q3 | $435M | Buy |
10,396,656
+3,428,767
| +49% | +$132M | 0.14% | 95 |
|
|
2018
Q2 | $240M | Sell |
6,967,889
-1,329,199
| -16% | -$45.4M | 0.08% | 200 |
|
|
2018
Q1 | $279M | Buy |
8,297,088
+2,496,926
| +43% | +$85.8M | 0.1% | 161 |
|
|
2017
Q4 | $199M | Sell |
5,800,162
-546,288
| -9% | -$18.6M | 0.07% | 243 |
|
|
2017
Q3 | $215M | Buy |
6,346,450
+253,698
| +4% | +$8.15M | 0.08% | 201 |
|
|
2017
Q2 | $194M | Sell |
6,092,752
-2,001,546
| -25% | -$63.1M | 0.09% | 198 |
|
|
2017
Q1 | $263M | Buy |
8,094,298
+1,200,295
| +17% | +$37.8M | 0.13% | 125 |
|
|
2016
Q4 | $212M | Sell |
6,894,003
-1,369,357
| -17% | -$41.8M | 0.11% | 159 |
|
|
2016
Q3 | $266M | Buy |
8,263,360
+94,438
| +1% | +$3.16M | 0.13% | 118 |
|
|
2016
Q2 | $273M | Buy |
8,168,922
+972,948
| +14% | +$31.1M | 0.15% | 111 |
|
|
2016
Q1 | $202M | Sell |
7,195,974
-2,920,318
| -29% | -$83.4M | 0.11% | 142 |
|
|
2015
Q4 | $310M | Sell |
10,116,292
-304,079
| -3% | -$9.57M | 0.14% | 119 |
|
|
2015
Q3 | $311M | Buy |
10,420,371
+4,986,579
| +92% | +$160M | 0.13% | 119 |
|
|
2015
Q2 | $173M | Sell |
5,433,792
-4,626,427
| -46% | -$151M | 0.07% | 239 |
|
|
2015
Q1 | $332M | Sell |
10,060,219
-2,570,917
| -20% | -$81.7M | 0.15% | 103 |
|
|
2014
Q4 | $373M | Buy |
12,631,136
+2,649,124
| +27% | +$76M | 0.15% | 120 |
|
|
2014
Q3 | $280M | Buy |
9,982,012
+3,314,724
| +50% | +$93M | 0.11% | 143 |
|
|
2014
Q2 | $188M | Sell |
6,667,288
-294,066
| -4% | -$8.38M | 0.08% | 198 |
|
|
2014
Q1 | $212M | Buy |
6,961,354
+483,154
| +7% | +$14.4M | 0.1% | 170 |
|
|
2013
Q4 | $188M | Buy |
6,478,200
+1,712,855
| +36% | +$49.9M | 0.09% | 185 |
|
|
2013
Q3 | $130M | Sell |
4,765,345
-5,957,102
| -56% | -$162M | 0.07% | 238 |
|
|
2013
Q2 | $285M | Buy |
+10,722,447
| New | +$296M | 0.16% | 77 |
|
Other funds holding PFE
VCM
VPM
Susquehanna International Group's PFE Position: Q1 2026 in Review
Susquehanna International Group reduced its Pfizer (PFE) stake by 68% in Q1 2026, selling an estimated $68.5M and leaving 1,186,035 shares worth $33.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1632.
Susquehanna International Group first reported a position in PFE in Q2 2013 and has held it in 50 quarters since. The position peaked at $965M in Q2 2013. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Susquehanna International Group held 1,186,035 shares of Pfizer worth $33.3M as of Q1 2026.
- Susquehanna International Group sold 2,572,047 Pfizer shares in Q1 2026, an estimated $68.5M.
- Pfizer made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #1632 holding.
- Susquehanna International Group first reported a position in Pfizer in Q2 2013 and has held it in 50 quarters since.
- Susquehanna International Group's Pfizer position peaked at $965M in Q2 2013.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.